Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin.

Conen, A; Weisser, M; Jörg, C Orasch; Battegay, M; Trampuz, A; Frei, R; Christen, S; Heim, D; Gratwohl, A; Flückiger, U

Conen, A; Weisser, M; Jörg, C Orasch; Battegay, M; Trampuz, A; Frei, R; Christen, S; Heim, D; Gratwohl, A; Flückiger, U.

Affiliation

Conen A; Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.

Transpl Infect Dis ; 10(1): 66-70, 2008 Feb.

Article in En | MEDLINE | ID: mdl-17511816

Subject(s)

Antifungal Agents/therapeutic use; Candida/drug effects; Candidiasis/drug therapy; Echinocandins/therapeutic use; Hematologic Neoplasms/complications; Adult; Candida/classification; Candidiasis/microbiology; Caspofungin; Female; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Lipopeptides; Middle Aged; Neutropenia/complications; Transplantation, Homologous/adverse effects; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Candida / Candidiasis / Hematologic Neoplasms / Echinocandins / Antifungal Agents Limits: Adult / Female / Humans / Middle aged Language: En Journal: Transpl Infect Dis Year: 2008 Document type: Article

Search on Google

XML

PubMed Links